PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
CRH plc (CRH)
114.271.68 (1.49%)
111.48 - 114.40
76.75 - 114.40
5.09M / 4.23M (Avg.)
23.96 | 4.77
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-63.74%
Both firms have declining sales. Martin Whitman would suspect an industry slump or new disruptive entrants.
-73.24%
Both firms have negative gross profit growth. Martin Whitman would question the sector’s viability or cyclical slump.
-99.92%
Both companies show negative EBIT growth. Martin Whitman would consider macro or sector-specific headwinds.
-99.92%
Both companies face negative operating income growth. Martin Whitman would suspect broader market or cost hurdles.
-101.60%
Negative net income growth while VMC stands at 1.09%. Joel Greenblatt would push for a reevaluation of cost or revenue strategies.
-102.14%
Negative EPS growth while VMC is at 1.11%. Joel Greenblatt would expect urgent managerial action on costs or revenue drivers.
-102.16%
Negative diluted EPS growth while VMC is at 1.12%. Joel Greenblatt would require immediate efforts to restrain share issuance or boost net income.
-0.98%
Share reduction while VMC is at 0.15%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-1.87%
Reduced diluted shares while VMC is at 0.00%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
-100.00%
Dividend reduction while VMC stands at 7.56%. Joel Greenblatt would question the firm’s cash flow stability or capital allocation decisions.
-121.11%
Both companies show negative OCF growth. Martin Whitman would analyze broader economic or industry conditions limiting cash flow.
-144.54%
Both companies show negative FCF growth. Martin Whitman would consider an industry-wide capital spending surge or margin compression.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-100.00%
Both reduce receivables yoy. Martin Whitman suspects a shift in the entire niche’s credit approach or softer demand.
1.96%
Inventory growth well above VMC's 1.09%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
1.76%
Positive asset growth while VMC is shrinking. John Neff sees potential for us to outgrow the competitor if returns are solid.
-3.50%
We have a declining book value while VMC shows 0.69%. Joel Greenblatt sees a fundamental disadvantage in net worth creation vs. the competitor.
1.28%
We have some new debt while VMC reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
No Data
No Data available this quarter, please select a different quarter.
-53.75%
Both reduce SG&A yoy. Martin Whitman sees a cost war or cyclical slowdown forcing overhead cuts.